Ted Sweetser discusses turning information into usable datasets and pulling insights from them.
Author - David Miller
Déjà Vu: OPDP Again Targets Provider Branded Website of...
By Sarah Wicks & Dara Katcher Levy — FDA’s Office of Prescription Drug Promotion (OPDP) issued...
FDA Announces New Policy on Advisory Committee Members
The policy announced by Commissioner Martin A. Makary, MD, will not preclude employees of regulated...
FDA Updates Prescribing Information for Bristol Myers Squibb’s...
The simplified requirements for Camzyos are expected to ease prior contraindications, thereby...
Balancing Cost Control with Innovation Amidst Tariffs
Lynlee Brown discusses the decisions that companies must make to adjust to the tariffs while also...
Opinion: The ‘yes, and’ approach to dementia care
When a person with dementia gets something fundamental wrong — the year it is, your relationship...
ASCA 2024 Performance Update: Can ASCA Improve Submission...
By Lisa M. Baumhardt, Principal Medical Device Regulatory Expert — In January 2025, FDA posted...
Inside Lonza CHI’s Innovation Engine: Future-Ready Capsules...
How Lonza Capsules & Health Ingredients (CHI) is redefining drug delivery with cutting-edge capsule...
Expanding Immune Response Testing to Support Vaccine Development
Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune...
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing...
With combined investments exceeding $53 billion, both companies are deepening their US presence...